Recent Press Releases

GSK begins shipping 2014-15 U.S. flu vaccines

GSK begins shipping 2014-15 U.S. flu vaccines Expected 28 - 33 million doses of four-strain and three-strain flu shots will help meet U.S. public health needs GSK [LSE/NYSE: GSK] announced today it...

Novartis maintained strong innovation momentum in second quarter, while reconfirming full year outlook

Novartis maintained strong innovation momentum in second quarter, while reconfirming full year outlook Net sales grew 2%[1] in Q2, with core operating leverage across Q2 and H1 Net sales of USD 14.6...

The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries

The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries GENEVA, July 17, 2014 /PRNewswire via COMTEX/ -- GENEVA,...

Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product

Mylan Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Apotex; Apotex Can No Longer Supply Authorized Generic Product PITTSBURGH, July 17, 2014 /PRNewswire/ -- Mylan Inc....

New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease

Study Results Presented at the Alzheimer's Association International Conference 2014

INDIANAPOLIS, July 16,

Abbott Reports Second-Quarter 2014 Results

- Second-Quarter Ongoing EPS of $0.54, Above Previous Guidance Range and Representing Double-Digit Earnings-Per-Share Growth -

ABBOTT PARK, Ill.,

Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies

OXFORD, England and INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Im

Pfizer to Acquire InnoPharma, Inc.

Pfizer to Acquire InnoPharma, Inc. InnoPharma Has Established Track Record in the Development of Hard-to-Make, Differentiated, Sterile Injectable Products Portfolio of 10 Approved Products and...

New Data Shows Cognitive Impairment Precedes and Predicts Subsequent Functional Impairment in Patients with Mild Alzheimer's Disease

Study Results Presented at the Alzheimer's Association International Conference 2014

INDIANAPOLIS, July 15,

Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan

Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan LAVAL, Quebec, July 14, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. today announced it has...

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction Registration Statement on Form S-4 Declared Effective by SEC Record Dates for Mallinckrodt and Questcor Set for...

Johnson & Johnson Reports 2014 Second-Quarter Results:

Johnson & Johnson Reports 2014 Second-Quarter Results Sales of $19.5 Billion increased 9.1% Versus 2013 Second Quarter; Second-Quarter EPS was $1.51 Excluding Special Items, 2014 Second-Quarter...

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction

Brings Differentiated, Attractive Product Portfolio and Enhanced Commercial Platform, Diversifying Mylan's Business and Adding New Sales Channels in Acquired Markets

Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan

Abbott will retain its branded generics pharmaceuticals business in emerging markets

ABBOTT PARK, Ill., Jul

Update re: AbbVie Proposal

14 Jul 2014 Update re: AbbVie Proposal NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE...

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction

Mylan To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In An All-Stock Transaction Brings Differentiated, Attractive Product Portfolio and Enhanced...

New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice

Study Results Presented at the Alzheimer's Association International Conference 2014

INDIANAPOLIS, July 13,

Merck Presents "Premio Letterario Merck" in Rome

• Carlo Rovelli and Francisco Gonzales-Crussi win renowned literature award for "building bridges between literature and science" • Karl-Ludwig Kley: "Through the...

Lilly for Better Health™ expands website's non-product-branded health education resources, focuses on healthy behavior skills

INDIANAPOLIS, July 10, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has rebooted the Lilly

Abbott Builds Long-Term Commitment in China

ABBOTT PARK, Ill., July 10, 2014 /PRNewswire/ -- Today's announcement of a proposed strategic alliance with Fonterra to develop dairy far